Esther C.W. Breij

Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

Marije B. Overdijk, Sandra Verploegen, Marijn Bögels et al. · mAbs · 2015 · 503 citations · Full text

Medicine, Immunology, Oncology +17

Homogeneity of active demyelinating lesions in established multiple sclerosis

Esther C.W. Breij, Bianca P. Brink, Rob Veerhuis et al. · Annals of Neurology · 2008 · 353 citations

Medicine, Neurology, Pathology +17

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors

Julia Boshuizen, Louise A. Koopman, Oscar Krijgsman et al. · Nature Medicine · 2018 · 223 citations

Medicine, Oncology, Pharmacology +17

An Antibody–Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors

Esther C.W. Breij, Bart E.C.G. de Goeij, Sandra Verploegen et al. · Cancer Research · 2013 · 221 citations · Full text

Pharmacy, Oncology, Pharmacology +17

The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions

Bianca P. Brink, Robert Veerhuis, Esther C.W. Breij et al. · Journal of Neuropathology & Experimental Neurology · 2005 · 189 citations · Full text

Medicine, Neurology, Pathology +17